ly 255283 has been researched along with Respiratory Distress Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, MP; Fleisch, JH; Menconi, MJ; O'Sullivan, BP; Wang, H; Wollert, PS; Youssef, ME | 1 |
| Fink, MP; Larkin, V; Menconi, MJ; O'Sullivan, BP; Wang, H; Wollert, PS | 1 |
2 other study(ies) available for ly 255283 and Respiratory Distress Syndrome
| Article | Year |
|---|---|
A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine model.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Evaluation, Preclinical; Escherichia coli Infections; Extravascular Lung Water; Hemodynamics; Leukotriene B4; Male; Peroxidase; Proteins; Random Allocation; Respiratory Distress Syndrome; Shock, Septic; Swine; Tetrazoles; Thromboxane B2 | 1993 |
LY255283, a novel leukotriene B4 receptor antagonist, limits activation of neutrophils and prevents acute lung injury induced by endotoxin in pigs.
Topics: Acute Disease; Animals; Dose-Response Relationship, Drug; Lipopolysaccharides; Male; Neutrophils; Receptors, Immunologic; Receptors, Leukotriene B4; Respiratory Distress Syndrome; Swine; Tetrazoles | 1993 |